Dr. Reddy's Announces the Launch of Three Generic Drugs in the US

Dr. Reddy's Announces the Launch of Three Generic Drugs in the USIndian pharmaceutical company, Dr. Reddy's Laboratories today announced the launch of three drugs in the US market. The two drugs are approved by the US drug regulator and are designed to treat central nervous system disorders.

The first drug launched by the company is Donepezil Hydrochloride, which is a recreation of Japan based Eisai Pharma's Aricept. The second drug released is Venlafaxine Hydrochloride, which is an imitator of Wyeth's Effexor XR. The drug is designed to treat depression and social anxiety.

Dr Reddy's drug Venlafaxine Hydrochloride will have to compete with bigger players of the market such as Mylan and Teva. The capsules of the new drug will be available in the market in 37.5mg, 75mg and 150mg strengths.

The sale of drug, Donepezil Hydrochloride in the US only, helped the company in gaining $ 2 billion for the financial year 2011. The drug is available in 5mg and 10mg strengths in 30, 90 and 500 count bottles.

After the announcement of the new drugs in the US, the shares of Reddy's laboratories' gained 1.66% during the day's trade on the Bombay Stock Exchange and were traded at Rs 1604.60.